volume 37, issue 3, P215-217 2004
DOI: 10.1590/s0037-86822004000300004
View full text
|
|
Share

Abstract: The adverse effects of primaquine (0.50 mg/kg/day) were investigated in eleven patients with vivax malaria (three patients with glucose-6-phosphate dehydrogenase deficiency). Clinical and laboratorial alterations indicated acute hemolysis in only the enzymopenic patients and treatment was interrupted. Our results suggest that screening for G6PD deficiency should be carried out in patients with vivax malaria infection in order to avoid complications due to primaquine.

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

1
5
0
4

Publication Types

Select...

Relationship

0
0

Authors

Journals